Latest Strategy Changes News

Global Uranium and Enrichment Limited’s investee Ubaryon has sealed a binding agreement with uranium giant Urenco, unlocking a A$5 million investment and technical collaboration to accelerate a novel uranium enrichment technology.

OpenLearning Limited reported a robust Q2 FY25 with 22% year-on-year SaaS ARR growth to $2.65 million, driven by significant multi-year contract wins and expanding global customer base. The company’s AI-powered LMS strategy is delivering larger deals and improved cash flow metrics.

Iondrive Limited advances its proprietary battery recycling technology with a pilot plant design, European consortium formation, and new e-waste initiatives, supported by significant grant funding.

Brazilian Rare Earths Limited (BRE) confirms Sulista West as an ultra high-grade rare earth project with exceptional drill results and reports metallurgical breakthroughs at Monte Alto, underpinning its integrated supply chain ambitions.

Strickland Metals reports robust drilling results at its Serbian Rogozna Project, confirming significant gold and base metal mineralisation, while securing a $45 million equity deal for its Yandal Project in Western Australia.

Bannerman Energy reported a robust $80 million cash inflow from financing in Q2 2025, offsetting significant exploration expenditures and maintaining a strong cash position.

Cavalier Resources progresses its Crawford Gold Project with key milestones including an $11 million stream finance negotiation with Raptor Capital and the appointment of Colin Bald as General Manager of Operations.

SomnoMed reports a robust Q4 FY25 with 25% revenue growth and a milestone of treating over 1 million patients, while gearing up for significant capacity expansion and clinical advancements.

Avecho Biotechnology reports strong progress in its Phase III clinical trial for a CBD-based insomnia treatment, with recruitment accelerating across multiple Australian sites and interim results expected early next year.

Tigers Realm Coal’s planned sale of its Russian subsidiaries faces significant delays and a pricing impasse, with regulatory hurdles and sanctions complicating the exit process and triggering an ASX trading suspension.

Vitasora Health Limited reported a remarkable 226% increase in patient programs and secured an $11 million capital raise, positioning the company for accelerated growth and a path to cash flow breakeven in late 2026.

Elementos Limited has delivered a robust Definitive Feasibility Study for its Oropesa Tin Project in Spain, secured a $5 million strategic investment from Metals X, and progressed exploration at its Cleveland Tin Project in Tasmania.